Although most SCN1A-associated epilepsies are considered a loss-of-function disease, our results put L1624Q into a growing set of mixed gain and loss-of-function variants in SCN1A responsible for an increasing set of epilepsy phenotypes (Meng et al., 2015). Here, SCN1A is linked to epilepsy.